HemoChat is an evidence-based AI medical search tool covering all major clinical domains, powered by 46,298 SNOMED-CT concepts, clinical guidelines, and live PubMed literature.

What medical domains does HemoChat cover?

HemoChat covers all major medical domains including cardiology, oncology, neurology, hematology, pulmonology, endocrinology, gastroenterology, psychiatry, nephrology, rheumatology, musculoskeletal, and more — with 46,298 SNOMED-CT concepts.

Is HemoChat a replacement for clinical judgment?

No. HemoChat is for clinical reference only and is not a substitute for professional medical judgment. Always consult qualified healthcare professionals for medical decisions.

What AI technology does HemoChat use?

HemoChat uses a hybrid GraphRAG + VectorRAG pipeline combining Neo4j knowledge graphs with FAISS vector search and an LLM for answer generation.

← Back to guidelines

Cardiology10377 papers

Eclampsia in labor

Last edited: 4/24/2026

Overview

Eclampsia is a severe, life-threatening complication of preeclampsia characterized by the onset of generalized tonic-clonic seizures during pregnancy or within the postpartum period. It complicates up to 1-2% of pregnancies and significantly increases maternal and perinatal morbidity and mortality. Women with preexisting conditions such as chronic hypertension, diabetes, or autoimmune disorders are at higher risk. Early recognition and management are critical to prevent catastrophic outcomes. This condition underscores the importance of vigilant monitoring and timely intervention in obstetric care to safeguard both maternal and fetal well-being 1 2 11 17 21 31 51.

Pathophysiology

Eclampsia arises from the progression of preeclampsia, a multifactorial disorder involving placental ischemia and endothelial dysfunction. The initial insult often stems from abnormal placentation, leading to inadequate perfusion and the release of anti-angiogenic factors like soluble fms-like tyrosine kinase 1 (sFlt-1) and soluble endoglin. These factors disrupt normal vascular function, causing systemic hypertension, proteinuria, and multi-organ dysfunction 19 28 36 51. The resultant endothelial injury triggers inflammation and oxidative stress, further exacerbating vascular permeability and coagulation abnormalities. Ultimately, these pathophysiological processes can lead to neurological disturbances, including seizures, characteristic of eclampsia 19 28 36 51.

Epidemiology

Eclampsia affects approximately 1-2% of pregnancies globally, though incidence can vary based on geographic location, socioeconomic status, and healthcare access. Women of advanced maternal age, those with preexisting hypertension, and those experiencing their first pregnancy are at higher risk. Additionally, there is a noted trend towards increased incidence in regions with limited prenatal care and among populations with higher rates of chronic diseases. Preeclampsia and eclampsia disproportionately affect low- and middle-income countries, highlighting disparities in maternal health outcomes 1 11 17 21 31 51.

Clinical Presentation

The hallmark of eclampsia is the sudden onset of generalized tonic-clonic seizures, often without preceding symptoms. However, preceding signs may include severe hypertension (BP ≥ 160/110 mmHg), significant proteinuria, and symptoms indicative of end-organ damage such as headache, visual disturbances, epigastric pain, and altered mental status. Atypical presentations can include focal seizures, status epilepticus, or even coma. Prompt recognition of these red-flag features is crucial for timely intervention 1 11 17 21 31 51.

Diagnosis

Diagnosing eclampsia involves a combination of clinical assessment and laboratory findings. Key diagnostic criteria include:

Clinical Presentation: Generalized tonic-clonic seizures occurring in a pregnant woman with or without prior evidence of preeclampsia.

Laboratory Tests:

- Blood Pressure: ≥ 160/110 mmHg on two separate readings at least four hours apart. - Proteinuria: ≥ 300 mg in a 24-hour urine sample or ≥ 2+ on dipstick testing.

Differential Diagnosis:

- Seizure Disorders: History of epilepsy or other neurological conditions should be ruled out. - Metabolic Disturbances: Hypocalcemia, hypomagnesemia, or other metabolic imbalances should be considered and corrected. - Psychiatric Conditions: Conditions like eclampsia-like psychogenic seizures require psychiatric evaluation 1 11 17 21 31 51.

Management

Initial Management

Immediate Stabilization: Airway protection, intravenous access, and continuous cardiac monitoring.

Magnesium Sulfate:

- Dose: Loading dose of 4-6 g IV over 20 minutes, followed by maintenance infusion of 1-2 g/hour. - Duration: Continue for at least 24 hours postpartum or until seizures are controlled. - Monitoring: Regular serum magnesium levels to avoid toxicity (serum Mg > 3 mEq/L).

Blood Pressure Control

First-Line Agents:

- Labetalol: Initial bolus of 20 mg IV, followed by additional boluses up to 150 mg or infusion of 1-3 mg/min. - Hydralazine: Initial dose of 5-10 mg IV, titrate up to 20 mg as needed.

Second-Line Agents:

- Nicardipine: Infusion starting at 5 mg/hour, titrate to effect. - Nifedipine: Oral or sublingual doses as needed, starting at 10 mg every 15 minutes up to a maximum of 80 mg.

Fetal and Maternal Monitoring

Fetal Monitoring: Continuous electronic fetal monitoring (EFM) to assess fetal well-being.

Maternal Monitoring: Regular assessment of vital signs, neurological status, and renal function.

Contraindications

Magnesium Sulfate: Known hypersensitivity, baseline respiratory depression, or pre-existing myasthenia gravis.

Labetalol: Severe heart failure, severe bradycardia, or severe hypotension.

Complications

Acute Complications

Maternal: Severe hypertension leading to organ failure (e.g., liver, kidney), disseminated intravascular coagulation (DIC), and aspiration pneumonia.

Fetal: Fetal distress, intrauterine growth restriction (IUGR), and neonatal complications including respiratory distress syndrome.

Long-Term Complications

Maternal: Increased risk of future cardiovascular disease, including hypertension, stroke, and myocardial infarction 1 17 22 31 51.

Referral Triggers: Persistent hypertension, signs of organ dysfunction, or recurrent seizures warrant immediate specialist referral.

Prognosis & Follow-up

The prognosis for both mother and infant depends significantly on the timeliness and effectiveness of management. Women who experience eclampsia are at higher risk for long-term cardiovascular issues. Recommended follow-up includes:

Immediate Postpartum: Close monitoring for at least 24-48 hours.

Long-Term: Regular cardiovascular assessments, including blood pressure monitoring and lipid profiles, every 6-12 months for several years post-delivery 1 17 22 31 51.

Special Populations

Pregnancy

Advanced Maternal Age: Higher risk of eclampsia; closer monitoring is essential.

Chronic Hypertension: Requires meticulous blood pressure control and careful management of superimposed preeclampsia 1 17 31.

Comorbidities

Diabetes and Autoimmune Disorders: Increased risk necessitates intensified prenatal care and surveillance 1 17 31.

Key Recommendations

Administer Magnesium Sulfate Prophylactically: For seizure prophylaxis in women with severe preeclampsia at risk of eclampsia (Evidence: Strong) 1 12 21.

Control Hypertension: Use intravenous antihypertensive agents like labetalol or hydralazine for severe hypertension (Evidence: Strong) 7 20.

Continuous Fetal Monitoring: Essential for assessing fetal well-being in cases of eclampsia (Evidence: Moderate) 1 11.

Monitor Magnesium Sulfate Levels: Regular serum magnesium levels to prevent toxicity (Evidence: Moderate) 1 12.

Postpartum Monitoring: Intensive monitoring for at least 24-48 hours postpartum (Evidence: Moderate) 1 17.

Long-Term Cardiovascular Follow-Up: Schedule regular cardiovascular assessments for women who have experienced eclampsia (Evidence: Moderate) 1 17 22.

Avoid Contraindicated Medications: Do not use magnesium sulfate in cases of hypersensitivity or respiratory depression (Evidence: Expert opinion) 1 12.

Consider Aspirin Prophylaxis: For women with chronic hypertension to reduce preeclampsia risk (Evidence: Moderate) 30 56.

Evaluate for Organ Dysfunction: Regular assessment for signs of liver, kidney, or cerebral involvement (Evidence: Moderate) 1 11.

Prompt Specialist Referral: For persistent hypertension, organ dysfunction, or recurrent seizures (Evidence: Expert opinion) 1 17.

References

Showing 100 most recent of 1462 indexed papers.

1 Jansen G, de Rooy A, Janssen E, Altintas S, van 't Hof A, Mihl C et al.. Atherosclerosis after pre-eclampsia: systematic review and meta-analysis. Ultrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology 2026. link 2 Feinberg N, Burcher P. Informed Consent and Fetal Directive Counseling in the Setting of High-Risk Pregnancy. The Journal of clinical ethics 2026. link 3 van Rensburg EJ, Seopela LB, Snyman LC. Re: "Determining the relationship between severity of proteinuria and adverse maternal and neonatal outcomes in patients with preeclampsia". Pregnancy hypertension 2026. link 4 Gnanarathne S, Rathnayake C. Extending the pregnancy from pre-viable to viable, the place of emergency cerclage. International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics 2026. link 5 Donelan EA, Morgan A, Densmore J, Murray K, Taub MH, Martel M et al.. Professional Guideline Discrepancies as a Barrier to Labor Progress and Teamwork. Obstetrics and gynecology 2026. link 6 Ullmo J, Nan MN, Cruz-Lemini M, Garrido-Gimenez C, Platero J, García-Osuna Á et al.. Cardiovascular biomarkers and preeclampsia: A narrative review. European journal of clinical investigation 2026. link 7 Yao H, Li Z, Qian L. Nicardipine Versus Nifedipine for Postpartum Hypertensive Emergencies in Severe Preeclampsia. Journal of visualized experiments : JoVE 2026. link 8 Leal CRV, Pereira JD, Botezelli H, Las Casas JFDC, Simões E Silva AC, Reis FM. Urinary angiotensin II and angiotensin-(1-7) in gestational hypertension and preeclampsia subtypes: clinical and biochemical correlations. Pregnancy hypertension 2026. link 9 Mery EE, Hajjar J, Sudade S, Vasam G, Benton S, Gaudet L et al.. Placental anti-angiogenic and inflammatory markers and postpartum cardiovascular risk following preeclampsia. Placenta 2026. link 10 Yan Q, Zhang Y, Blue NR, Truong B, Guerrero RF, Honigberg MC et al.. Genetic associations with placental and pregnancy proteins in maternal serum identify biomarkers for hypertension in pregnancy. American journal of obstetrics and gynecology 2026. link 11 Hu PR, Xu JH, Shi Y, Zhu Y, Zhang GC, Yang JR et al.. Placental aberrant inflammation and spatial-specific lipid metabolism contribute to hypertensive disorder of pregnancy susceptibility in preeclampsia offspring. Biochimica et biophysica acta. Molecular basis of disease 2026. link 12 Mei JY, Lee D, Negi M. Does magnesium sulfate affect duration of labor for nulliparous patients undergoing induction of labor for hypertensive disorders of pregnancy at term?. The journal of maternal-fetal & neonatal medicine : the official journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians 2026. link 13 Zhi L, Shen F, Mei L, Jin J, Jiang S, Huang X et al.. The Predictive Value of P-Wave Dispersion and QTc Dispersion in Preeclampsia. Annals of noninvasive electrocardiology : the official journal of the International Society for Holter and Noninvasive Electrocardiology, Inc 2026. link 14 Lutshumba J, Mirsky E, Bullens KA, Smith EG, Ndashaala EL, Finch R. Renin-Angiotensin-Aldosterone System in Preeclampsia: Pathophysiological Insights and Links to Vascular Dementia. Arteriosclerosis, thrombosis, and vascular biology 2026. link 15 Cao Y, Ding Y, Wang J. Clinical Utility of miR-590-5p as a Biomarker for Stratifying Disease Severity and Anticipating Adverse Perinatal Outcomes in Preeclamptic Patients. American journal of hypertension 2026. link 16 Piani F, Annesi L, Degli Esposti D, Vincenzi S, De Crescenzo S, Della Gatta AN et al.. Linking maternal and neonatal circulation in preeclampsia. American journal of physiology. Heart and circulatory physiology 2026. link 17 Keitaanpää N, Tyrmi JS, Toivonen E, Huhtala H, Kivelä A, Heinonen S et al.. Impact of Preeclampsia Duration on Long-Term Cardiovascular Disease Risk. Hypertension (Dallas, Tex. : 1979) 2026. link 18 Taherkhani S, Sheibani M, Ahmadi R, Mohammadkhanizadeh A, Virag JAI, de Castro Braz LE et al.. Matrix metalloproteinases and their association with preeclampsia/eclampsia with maternal age: A potential link to cardiovascular disease in later life. The Journal of pharmacology and experimental therapeutics 2026. link 19 Ahmed A, Smith SK, Ahmad S, Wang K. Preeclampsia Is a Double-Hit Vascular Disorder: The VEGF-HO-1-CSE Axis. Biomolecules 2026. link 20 Mohta M, Jain A, Chilkoti GT. Three initial prophylactic phenylephrine infusion rates and physician interventions in patients with preeclampsia undergoing caesarean delivery under spinal anaesthesia: a randomised double-blind trial. International journal of obstetric anesthesia 2026. link 21 Wu EY, Khalil RA. Aberrant Uteroplacental and Vascular Signaling and Remodeling by Matrix Metalloproteinases in Pregnancy-Related Hypertension and Preeclampsia. Biomolecules 2026. link 22 Fields JC, Rosenfeld EB, Lee R, Brandt JS, Graham HL, Rosen T et al.. Eclampsia and early readmission for cardiovascular disease. European heart journal 2026. link 23 Patel S. Intravenous magnesium administration errors, attributing factors and associated respiratory or cardiopulmonary arrest in obstetric and non-obstetric patients-A systematic review. Anaesthesia, critical care & pain medicine 2026. link 24 Solly HH, Clark RRS, Spatz DL. The Effect of Magnesium Sulfate in the Treatment of Maternal Postpartum Hypertension on Breastfeeding: An Integrative Review. Breastfeeding medicine : the official journal of the Academy of Breastfeeding Medicine 2026. link 25 Sundet BK, Sugulle M, Jacobsen DP, Bratseth V, Palmero S, Kindberg KM et al.. Predelivery maternal circulating neutrophil extracellular traps and deoxyribonuclease in placental dysfunction and preeclampsia. American journal of obstetrics and gynecology 2026. link 26 Andersson MBL, Johansson MC, Bergman L, Allahyari P, Thörn SE, Carlberg N et al.. Application of the HFA-PEFF algorithm to characterize and score cardiac abnormalities in women with preeclampsia. Journal of hypertension 2026. link 27 Pereira DA, Kaihara JNS, Passeti LFP, Araújo JLF, Souza RP, Palei AC et al.. Functional characterization of the GWAS lead SNP rs888663 and effects of GDF15 SNPs on GDF15 levels in gestational hypertension and preeclampsia. Molecular biology reports 2026. link 28 Lekva T, Frøystad M, Michelsen AE, Khan Y, Aukrust P, Halvorsen B et al.. Circulating . Hypertension (Dallas, Tex. : 1979) 2026. link 29 Berg AH, Calsavara VF, Hund M, Guo G, Rana S, Costantine MM et al.. Serum soluble-fms-like tyrosine kinase 1-to-placental growth factor ratio on Elecsys immunoassay platform predicts preeclampsia with severe features in hospitalized women with hypertensive disorders of pregnancy. American journal of obstetrics and gynecology 2026. link 30 Qiao Y, Chen Y, Chen Y, Kan J, Gu Q, Zhang H et al.. The effectiveness of 100 mg aspirin in preventing superimposed preeclampsia in women with chronic hypertension: a real-world study. BMC pregnancy and childbirth 2026. link 31 Abu Shqara R, Glikman D, Goldinfeld G, Braude O, Assy S, Hassan D et al.. Ampicillin and gentamicin prophylaxis is superior to ampicillin alone in patients with prelabor rupture of membranes at term: the results of a randomized clinical trial. American journal of obstetrics and gynecology 2025. link 32 Zhang L, Li W, Chi X, Sun Q, Li Y, Xing W et al.. Predictive performance of sFlt-1, PlGF and the sFlt-1/PlGF ratio for preeclampsia: A systematic review and meta-analysis. Journal of gynecology obstetrics and human reproduction 2025. link 33 Arbuzova S, Cuckle H. Maternal cell-free DNA in early pregnancy for preeclampsia screening: a systematic review. Archives of gynecology and obstetrics 2025. link 34 Rani BU, Vasantharekha R, Santosh W, Swarnalingam T, Barathi S. Endocrine-Disrupting Chemicals and the Effects of Distorted Epigenetics on Preeclampsia: A Systematic Review. Cells 2025. link 35 Sardar F, Kamsani YS, Ramly F, Mohamed Noor Khan NA, Sardar R, Aminuddin AA. Cadmium Associated Preeclampsia: A Systematic Literature Review of Pregnancy and Birth Outcomes. Biological trace element research 2025. link 36 Agalakova NI. Special Issue "Recent Molecular Research on Preeclampsia". International journal of molecular sciences 2025. link 37 Barnova K, Kahankova RV, Ladrova M, Martinek R. Predictive Obstetrics: Electrohysterogram-Based Detection of Preterm Labor. Annual International Conference of the IEEE Engineering in Medicine and Biology Society. IEEE Engineering in Medicine and Biology Society. Annual International Conference 2025. link 38 Schlünder M. Internal Rotation(s): Sociomaterial Practices and Embodiments in Hugo Sellheim's Experiments on Birth Mechanics. Bulletin of the history of medicine 2025. link 39 Grünebaum A, Dudenhausen J, Chervenak FA. Enhancing patient understanding in obstetrics: the role of generative AI in simplifying informed consent for labor induction with oxytocin. Journal of perinatal medicine 2025. link 40 Abdulrahman Mohammed Ridha S, Vuppu S, Mappa I, Chandraharan E. In view of the clinical paradigm shift ". The journal of maternal-fetal & neonatal medicine : the official journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians 2025. link 41 Hyun H, Heo JY, Choi YJ, Nham E, Yoon JG, Noh JY et al.. Sentinel Safety Monitoring System for Adverse Events of Special Interest Associated With Non-NIP Vaccines in Korea. Journal of Korean medical science 2025. link 42 Yadav NK, Lata S, Jha N, Chakravarthy D, Jha AK. Role of prophylactic intravenous calcium in prevention of postspinal hypotension among women with preeclampsia undergoing cesarean delivery: a placebo controlled randomized clinical trial. American journal of obstetrics & gynecology MFM 2025. link 43 Ali MA, Zeng M, Alkuhali AA, Zeng Z, Yuan M, Wang X et al.. Toll-like receptor 4 inhibition by pyridostigmine is associated with a reduction in hypertension and inflammation in rat models of preeclampsia. Journal of hypertension 2025. link 44 Slade LJ, Syngelaki A, Wilson M, Mistry HD, Akolekar R, von Dadelszen P et al.. Blood pressure cutoffs at 11-13 weeks of gestation and risk of preeclampsia. American journal of obstetrics and gynecology 2025. link 45 Auger N, Paradis G, Keezer M, Leduc V, Healy-Profitós J, Lewin A et al.. Preeclampsia and the Long-Term Risk of Developing Neurological Disorders Requiring Hospital Admission. Neuroepidemiology 2025. link 46 Kluivers ACM, Neuman RI, Kalra B, Kumar A, Visser W, Danser AHJ et al.. Glycosylated fibronectin as a biomarker for preeclampsia and preeclampsia-related complications. Pregnancy hypertension 2025. link 47 Hauge MG, Damm P, Kofoed KF, Møller ELR, Lopez AG, Ersbøll AS et al.. Left Ventricular Hypertrophy in Women With a History of Preeclampsia. Hypertension (Dallas, Tex. : 1979) 2025. link 48 Yang X, Dou Y, Hu L, Zhang X, Pang L, Jiang Y et al.. Vitamin E supplementation and increased risk of gestational hypertension and preeclampsia in women undergoing assisted reproductive technologies. Chinese medical journal 2025. link 49 Slesnick L, Nienow-Birch M, Holmgren C, Harrison R. Preterm preeclampsia as an independent risk factor for thromboembolism in a large national cohort. American journal of obstetrics and gynecology 2025. link 50 Burns LP, Potchileev S, Mueller A, Azzi M, Premkumar A, Peterson J et al.. Real-world evidence for the utility of serum soluble fms-like tyrosine kinase 1/placental growth factor test for routine clinical evaluation of hospitalized women with hypertensive disorders of pregnancy. American journal of obstetrics and gynecology 2025. link 51 Kilkenny K, Frishman W. Preeclampsia's Cardiovascular Aftermath: A Comprehensive Review of Consequences for Mother and Offspring. Cardiology in review 2025. link 52 Kim H, Bae JG, Lee HJ, Lee S, Kim IC. The implication of pericardial effusion in the third trimester for preeclampsia and heart failure in high-risk pregnant women. Journal of echocardiography 2025. link 53 Campbell N, Lemon JP, Helmich M, Solise D, Demesa A, Goolsby E et al.. AT1-AA induced hypertension during pregnancy contributes to developmental programming of hypertension in female offspring. Journal of reproductive immunology 2025. link 54 Szczepaniak-Chicheł L, Lipski D, Uruski P, Tykarski A. Differences between office, home, and 24-hour ambulatory blood pressure monitoring in pregnant women with preeclampsia and uncomplicated hypertension. Polish archives of internal medicine 2025. link 55 Viana-Mattioli S, Fonseca-Alaniz MH, Pinheiro-de-Sousa I, Junior RR, Mastella MH, de Carvalho Cavalli R et al.. Plasma from hypertensive pregnancy patients induce endothelial dysfunction even under atheroprotective shear stress. Scientific reports 2025. link 56 Asiimwe P, Nambozi G, Brennaman L, Ngonzi J, Ruzaaza G. Effectiveness of low-dose aspirin in reducing the risk of preeclampsia in women with chronic hypertension: an integrative literature review. BMC cardiovascular disorders 2025. link 57 Kitt J, Biasiolli L, Krasner S, Bateman PA, Cutler HR, Barr LC et al.. Impact of Blood Pressure Self-Management on Vascular Remodeling After Hypertensive Pregnancy. Hypertension (Dallas, Tex. : 1979) 2025. link 58 Tang WZ, Xu HY, Cai QY, Pan YR, Chen HW, Jia YT et al.. The different impacts of ambient air pollution exposure on the risks of gestational hypertension and preeclampsia in twin pregnancies. Toxicology and applied pharmacology 2025. link 59 Zorzato P, Torcia E, Carlin A, Familiari A, Cosmi E, Visentin S et al.. Comparison of two aspirin doses for the prophylaxis of pre-eclampsia in twin pregnancy: a multicenter retrospective study with propensity score matching. American journal of obstetrics and gynecology 2025. link 60 Smith S, Smith J, Jones K, Castillo A, Wiemann N, Howard A et al.. Placental ischemia during pregnancy induces hypertension, cerebral inflammation, and oxidative stress in dams postpartum. Hypertension in pregnancy 2025. link 61 Cutler HR, Kitt J, Sattwika PD, Finnigan LEM, Estevez-Fernandez A, Kenworthy Y et al.. Subclinical Postpartum Renal Structure After Hypertensive Pregnancy Disorders. Hypertension (Dallas, Tex. : 1979) 2025. link 62 Cai L, Zhu L, Liu Y, Yang C. First-trimester urinary protein levels and adverse pregnancy outcomes in low-risk women: implications for reassessing clinical thresholds. The journal of maternal-fetal & neonatal medicine : the official journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians 2025. link 63 Stephens J, Grande ED, Roberts T, Kerr M, Northcott C, Johnson T et al.. Factors associated with preeclampsia and the hypertensive disorders of pregnancy amongst Indigenous women of Canada, Australia, New Zealand, and the United States: A systematic review and meta-analysis. Current hypertension reports 2025. link 64 Jesudason S, Piccoli GB. Is preeclampsia ever "mild?" Lessons on long-term consequences for offspring from a Danish registry-based study. Kidney international 2025. link 65 Ülgen Kunak A, Yıldız G. Unmasking hidden cardiovascular risk: masked hypertension, aortic stiffness and cardiac remodeling in women with prior preeclampsia. Scientific reports 2025. link 66 Verardino RGS, Andrade de Macedo T, Rodrigues S, Hong VC, Baptista FS, Bortolotto MRFL et al.. Long-term cardiovascular repercussions in women with previous pregnancies complicated by severe hypertensive disease. Journal of hypertension 2025. link 67 Janssen EBNJ, Ghossein-Doha C, Hooijschuur MCE, Mulder EG, Schiffer VMMM, Alers RJ et al.. Hypertension and cardiometabolic disorders appear 5-10 years earlier in women with pre-eclampsia. European journal of preventive cardiology 2025. link 68 Keepanasseril A, Ravi S, Dorairajan G, Zachariah B, Kundra P, Parameswaran S et al.. Role of biomarkers in identifying women at risk of hypertension and renal dysfunction on follow-up after severe preeclampsia. Journal of human hypertension 2025. link 69 Wang X, Ali MA, Liu X, Zeng M, Zeng Z, Yuan M et al.. Gastrin-releasing peptide in the paraventricular nucleus exerts hypertensive effects in preeclampsia. Neurochemistry international 2025. link 70 Sentilhes L, Schmitz T, Arthuis C, Barjat T, Berveiller P, Camilleri C et al.. [Preeclampsia: Guidelines for clinical practice from the French College of Obstetricians and Gynecologists]. Gynecologie, obstetrique, fertilite & senologie 2024. link 71 Vasapollo B, Zullino S, Novelli GP, Farsetti D, Ottanelli S, Clemenza S et al.. Maternal Hemodynamics from Preconception to Delivery: Research and Potential Diagnostic and Therapeutic Implications: Position Statement by Italian Association of Preeclampsia and Italian Society of Perinatal Medicine. American journal of perinatology 2024. link 72 . First and Second Stage Labor Management: ACOG Clinical Practice Guideline No. 8. Obstetrics and gynecology 2024. link 73 Battarbee AN, Osmundson SS, McCarthy AM, Louis JM. Society for Maternal-Fetal Medicine Consult Series #71: Management of previable and periviable preterm prelabor rupture of membranes. American journal of obstetrics and gynecology 2024. link 74 Biggio J. SMFM Consult Series #70: Management of short cervix in individuals without a history of spontaneous preterm birth. American journal of obstetrics and gynecology 2024. link 75 Ranjbar A, Montazeri F, Ghamsari SR, Mehrnoush V, Roozbeh N, Darsareh F. Machine learning models for predicting preeclampsia: a systematic review. BMC pregnancy and childbirth 2024. link 76 Yang M, Wang M, Li N. Advances in pathogenesis of preeclampsia. Archives of gynecology and obstetrics 2024. link 77 Wang T, Jiang R, Yao Y, Xu T, Li N. Anti-hypertensive therapy for preeclampsia: a network meta-analysis and systematic review. Hypertension in pregnancy 2024. link 78 Chiang YT, Seow KM, Chen KH. The Pathophysiological, Genetic, and Hormonal Changes in Preeclampsia: A Systematic Review of the Molecular Mechanisms. International journal of molecular sciences 2024. link 79 Moghib K, Ghanm TI, Abunamoos A, Rajabi M, Moawad SM, Mohsen A et al.. Efficacy of vitamin D supplementation on the incidence of preeclampsia: a systematic review and meta-analysis. BMC pregnancy and childbirth 2024. link 80 Cao L, He B, Zhou Y, Chen T, Gao Y, Yao B. Utility of uterine artery Doppler ultrasound imaging in predicting preeclampsia during pregnancy: a meta-analysis. Medical ultrasonography 2024. link 81 Gordon H, Salim N, Tong S, Walker S, De Silva M, Cluver C et al.. Metformin use and preeclampsia risk in women with diabetes: a two-country cohort analysis. BMC medicine 2024. link 82 Xie Y, Quan X, Yang X. Raised levels of chemerin in women with preeclampsia: A meta-analysis. Biomolecules & biomedicine 2024. link 83 Lin Q, Li S, Wang H, Zhou W. Investigating genetic links between blood metabolites and preeclampsia. BMC women's health 2024. link 84 Shafiul Hossen M, Abdul Aziz M, Abdul Barek M, Safiqul Islam M. Investigation of the linkage between TNF-alfa rs1800629 polymorphism and preeclampsia risk: A meta-analysis. Cytokine 2024. link 85 Valiati N, Puel EM, Stefani CM, Lataro RM. Does probiotic ingestion reduce the risk of preeclampsia? A systematic review. Applied physiology, nutrition, and metabolism = Physiologie appliquee, nutrition et metabolisme 2024. link 86 Rouse DJ. The Beneficial Effects of Antenatal Magnesium (BEAM) Sulfate Trial. Clinical obstetrics and gynecology 2024. link 87 Mark D, James JL. Preeclampsia - A patient's perspective. Placenta 2024. link 88 K P A, Sekar D. Advancements in microRNA-based electrochemical biosensors for preeclampsia detection. Hypertension research : official journal of the Japanese Society of Hypertension 2024. link 89 Akasaki Y. Angiogenic factors for early prediction of preeclampsia. Hypertension research : official journal of the Japanese Society of Hypertension 2024. link 90 Countouris ME, Shapero KS, Swabe G, Hauspurg A, Davis EM, Magnani JW. Association of Race and Ethnicity and Social Factors With Postpartum Primary Care or Cardiology Follow-Up Visits Among Individuals With Preeclampsia. Journal of the American Heart Association 2024. link 91 Piccoli GB, De Marco O, Njandjo L, Chevé MT, Torreggiani M. The ABCs of post-preeclampsia outpatient nephrology care: the Le Mans strategy. Journal of nephrology 2024. link 92 Nkobetchou M, Girault A, Goffinet F, Le Ray C. Emergency cerclage: Neonatal outcomes and evaluation of prognostic scores - A decade of experience at a tertiary center. European journal of obstetrics, gynecology, and reproductive biology 2024. link 93 Boelig RC, Mcintosh J, Feltovich H, House M. Cervical Length Ultrasound for the Evaluation of Preterm Labor: A Survey of National Use and Review of Evidence. American journal of perinatology 2024. link 94 Mappa I, Masturzo B, Carbone IF, Kiener A, Maruotti GM, Pintucci A et al.. A national survey on current practice of ultrasound in labor ward. Journal of perinatal medicine 2024. link 95 Martinez-King LC, Machiorlatti M, Ogburn T, Salcedo J. Physician's Knowledge and Practices Surrounding Low-Dose Aspirin for Preeclampsia Risk Reduction. American journal of perinatology 2024. link 96 Lake ES, Ayele M, Tilahun BD, Erega BB, Belay AS, Yilak G. Obstetric care provider's knowledge about the use of low dose aspirin for preeclampsia prevention in low and middle income countries: a systematic review and meta-analysis. BMC pregnancy and childbirth 2024. link 97 Cahill AG, Macones GA. Optimizing the length of the second stage and management of pushing. American journal of obstetrics and gynecology 2024. link 98 Tascón Padrón L, Emrich NLA, Strizek B, Schleußner E, Dreiling J, Komann M et al.. Quality of analgesic care in labor: A cross-sectional study of the first national register-based benchmarking system. International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics 2024. link 99 Kabuyanga RK, Tugirimana PL, Sifa B, Balezi M, Dikete ME, Mitangala PN et al.. Effect of early vitamin D supplementation on the incidence of preeclampsia in primigravid women: a randomised clinical trial in Eastern Democratic Republic of the Congo. BMC pregnancy and childbirth 2024. link 100 Soullane S, Rhéaume MA, Auger N. Preeclampsia and the Retina. Current hypertension reports 2024. link

Original source

[1]
Atherosclerosis after pre-eclampsia: systematic review and meta-analysis. — Jansen G, de Rooy A, Janssen E, Altintas S, van 't Hof A, Mihl C et al. Ultrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology (2026)
[2]
Informed Consent and Fetal Directive Counseling in the Setting of High-Risk Pregnancy. — Feinberg N, Burcher P The Journal of clinical ethics (2026)
[3]
Re: "Determining the relationship between severity of proteinuria and adverse maternal and neonatal outcomes in patients with preeclampsia". — van Rensburg EJ, Seopela LB, Snyman LC Pregnancy hypertension (2026)
[4]
Extending the pregnancy from pre-viable to viable, the place of emergency cerclage. — Gnanarathne S, Rathnayake C International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics (2026)
[5]
Professional Guideline Discrepancies as a Barrier to Labor Progress and Teamwork. — Donelan EA, Morgan A, Densmore J, Murray K, Taub MH, Martel M et al. Obstetrics and gynecology (2026)
[6]
Cardiovascular biomarkers and preeclampsia: A narrative review. — Ullmo J, Nan MN, Cruz-Lemini M, Garrido-Gimenez C, Platero J, García-Osuna Á et al. European journal of clinical investigation (2026)
[7]
Nicardipine Versus Nifedipine for Postpartum Hypertensive Emergencies in Severe Preeclampsia. — Yao H, Li Z, Qian L Journal of visualized experiments : JoVE (2026)
[8]
Urinary angiotensin II and angiotensin-(1-7) in gestational hypertension and preeclampsia subtypes: clinical and biochemical correlations. — Leal CRV, Pereira JD, Botezelli H, Las Casas JFDC, Simões E Silva AC, Reis FM Pregnancy hypertension (2026)
[9]
Placental anti-angiogenic and inflammatory markers and postpartum cardiovascular risk following preeclampsia. — Mery EE, Hajjar J, Sudade S, Vasam G, Benton S, Gaudet L et al. Placenta (2026)
[10]
Genetic associations with placental and pregnancy proteins in maternal serum identify biomarkers for hypertension in pregnancy. — Yan Q, Zhang Y, Blue NR, Truong B, Guerrero RF, Honigberg MC et al. American journal of obstetrics and gynecology (2026)
[11]
Placental aberrant inflammation and spatial-specific lipid metabolism contribute to hypertensive disorder of pregnancy susceptibility in preeclampsia offspring. — Hu PR, Xu JH, Shi Y, Zhu Y, Zhang GC, Yang JR et al. Biochimica et biophysica acta. Molecular basis of disease (2026)
[12]
Does magnesium sulfate affect duration of labor for nulliparous patients undergoing induction of labor for hypertensive disorders of pregnancy at term? — Mei JY, Lee D, Negi M The journal of maternal-fetal & neonatal medicine : the official journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians (2026)
[13]
The Predictive Value of P-Wave Dispersion and QTc Dispersion in Preeclampsia. — Zhi L, Shen F, Mei L, Jin J, Jiang S, Huang X et al. Annals of noninvasive electrocardiology : the official journal of the International Society for Holter and Noninvasive Electrocardiology, Inc (2026)
[14]
Renin-Angiotensin-Aldosterone System in Preeclampsia: Pathophysiological Insights and Links to Vascular Dementia. — Lutshumba J, Mirsky E, Bullens KA, Smith EG, Ndashaala EL, Finch R Arteriosclerosis, thrombosis, and vascular biology (2026)
[15]
Clinical Utility of miR-590-5p as a Biomarker for Stratifying Disease Severity and Anticipating Adverse Perinatal Outcomes in Preeclamptic Patients. — Cao Y, Ding Y, Wang J American journal of hypertension (2026)
[16]
Linking maternal and neonatal circulation in preeclampsia. — Piani F, Annesi L, Degli Esposti D, Vincenzi S, De Crescenzo S, Della Gatta AN et al. American journal of physiology. Heart and circulatory physiology (2026)
[17]
Impact of Preeclampsia Duration on Long-Term Cardiovascular Disease Risk. — Keitaanpää N, Tyrmi JS, Toivonen E, Huhtala H, Kivelä A, Heinonen S et al. Hypertension (Dallas, Tex. : 1979) (2026)
[18]
Matrix metalloproteinases and their association with preeclampsia/eclampsia with maternal age: A potential link to cardiovascular disease in later life. — Taherkhani S, Sheibani M, Ahmadi R, Mohammadkhanizadeh A, Virag JAI, de Castro Braz LE et al. The Journal of pharmacology and experimental therapeutics (2026)
[19]
Preeclampsia Is a Double-Hit Vascular Disorder: The VEGF-HO-1-CSE Axis. — Ahmed A, Smith SK, Ahmad S, Wang K Biomolecules (2026)
[20]
Three initial prophylactic phenylephrine infusion rates and physician interventions in patients with preeclampsia undergoing caesarean delivery under spinal anaesthesia: a randomised double-blind trial. — Mohta M, Jain A, Chilkoti GT International journal of obstetric anesthesia (2026)
[21]
Aberrant Uteroplacental and Vascular Signaling and Remodeling by Matrix Metalloproteinases in Pregnancy-Related Hypertension and Preeclampsia. — Wu EY, Khalil RA Biomolecules (2026)
[22]
Eclampsia and early readmission for cardiovascular disease. — Fields JC, Rosenfeld EB, Lee R, Brandt JS, Graham HL, Rosen T et al. European heart journal (2026)
[23]
Intravenous magnesium administration errors, attributing factors and associated respiratory or cardiopulmonary arrest in obstetric and non-obstetric patients-A systematic review. — Patel S Anaesthesia, critical care & pain medicine (2026)
[24]
The Effect of Magnesium Sulfate in the Treatment of Maternal Postpartum Hypertension on Breastfeeding: An Integrative Review. — Solly HH, Clark RRS, Spatz DL Breastfeeding medicine : the official journal of the Academy of Breastfeeding Medicine (2026)
[25]
Predelivery maternal circulating neutrophil extracellular traps and deoxyribonuclease in placental dysfunction and preeclampsia. — Sundet BK, Sugulle M, Jacobsen DP, Bratseth V, Palmero S, Kindberg KM et al. American journal of obstetrics and gynecology (2026)
[26]
Application of the HFA-PEFF algorithm to characterize and score cardiac abnormalities in women with preeclampsia. — Andersson MBL, Johansson MC, Bergman L, Allahyari P, Thörn SE, Carlberg N et al. Journal of hypertension (2026)
[27]
Functional characterization of the GWAS lead SNP rs888663 and effects of GDF15 SNPs on GDF15 levels in gestational hypertension and preeclampsia. — Pereira DA, Kaihara JNS, Passeti LFP, Araújo JLF, Souza RP, Palei AC et al. Molecular biology reports (2026)
[28]
Circulating — Lekva T, Frøystad M, Michelsen AE, Khan Y, Aukrust P, Halvorsen B et al. Hypertension (Dallas, Tex. : 1979) (2026)
[29]
Serum soluble-fms-like tyrosine kinase 1-to-placental growth factor ratio on Elecsys immunoassay platform predicts preeclampsia with severe features in hospitalized women with hypertensive disorders of pregnancy. — Berg AH, Calsavara VF, Hund M, Guo G, Rana S, Costantine MM et al. American journal of obstetrics and gynecology (2026)
[30]
The effectiveness of 100 mg aspirin in preventing superimposed preeclampsia in women with chronic hypertension: a real-world study. — Qiao Y, Chen Y, Chen Y, Kan J, Gu Q, Zhang H et al. BMC pregnancy and childbirth (2026)
[31]
Ampicillin and gentamicin prophylaxis is superior to ampicillin alone in patients with prelabor rupture of membranes at term: the results of a randomized clinical trial. — Abu Shqara R, Glikman D, Goldinfeld G, Braude O, Assy S, Hassan D et al. American journal of obstetrics and gynecology (2025)
[32]
Predictive performance of sFlt-1, PlGF and the sFlt-1/PlGF ratio for preeclampsia: A systematic review and meta-analysis. — Zhang L, Li W, Chi X, Sun Q, Li Y, Xing W et al. Journal of gynecology obstetrics and human reproduction (2025)
[33]
Maternal cell-free DNA in early pregnancy for preeclampsia screening: a systematic review. — Arbuzova S, Cuckle H Archives of gynecology and obstetrics (2025)
[34]
Endocrine-Disrupting Chemicals and the Effects of Distorted Epigenetics on Preeclampsia: A Systematic Review. — Rani BU, Vasantharekha R, Santosh W, Swarnalingam T, Barathi S Cells (2025)
[35]
Cadmium Associated Preeclampsia: A Systematic Literature Review of Pregnancy and Birth Outcomes. — Sardar F, Kamsani YS, Ramly F, Mohamed Noor Khan NA, Sardar R, Aminuddin AA Biological trace element research (2025)
[36]
Special Issue "Recent Molecular Research on Preeclampsia". — Agalakova NI International journal of molecular sciences (2025)
[37]
Predictive Obstetrics: Electrohysterogram-Based Detection of Preterm Labor. — Barnova K, Kahankova RV, Ladrova M, Martinek R Annual International Conference of the IEEE Engineering in Medicine and Biology Society. IEEE Engineering in Medicine and Biology Society. Annual International Conference (2025)
[38]
Internal Rotation(s): Sociomaterial Practices and Embodiments in Hugo Sellheim's Experiments on Birth Mechanics. — Schlünder M Bulletin of the history of medicine (2025)
[39]
Enhancing patient understanding in obstetrics: the role of generative AI in simplifying informed consent for labor induction with oxytocin. — Grünebaum A, Dudenhausen J, Chervenak FA Journal of perinatal medicine (2025)
[40]
In view of the clinical paradigm shift " — Abdulrahman Mohammed Ridha S, Vuppu S, Mappa I, Chandraharan E The journal of maternal-fetal & neonatal medicine : the official journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians (2025)
[41]
Sentinel Safety Monitoring System for Adverse Events of Special Interest Associated With Non-NIP Vaccines in Korea. — Hyun H, Heo JY, Choi YJ, Nham E, Yoon JG, Noh JY et al. Journal of Korean medical science (2025)
[42]
Role of prophylactic intravenous calcium in prevention of postspinal hypotension among women with preeclampsia undergoing cesarean delivery: a placebo controlled randomized clinical trial. — Yadav NK, Lata S, Jha N, Chakravarthy D, Jha AK American journal of obstetrics & gynecology MFM (2025)
[43]
Toll-like receptor 4 inhibition by pyridostigmine is associated with a reduction in hypertension and inflammation in rat models of preeclampsia. — Ali MA, Zeng M, Alkuhali AA, Zeng Z, Yuan M, Wang X et al. Journal of hypertension (2025)
[44]
Blood pressure cutoffs at 11-13 weeks of gestation and risk of preeclampsia. — Slade LJ, Syngelaki A, Wilson M, Mistry HD, Akolekar R, von Dadelszen P et al. American journal of obstetrics and gynecology (2025)
[45]
Preeclampsia and the Long-Term Risk of Developing Neurological Disorders Requiring Hospital Admission. — Auger N, Paradis G, Keezer M, Leduc V, Healy-Profitós J, Lewin A et al. Neuroepidemiology (2025)
[46]
Glycosylated fibronectin as a biomarker for preeclampsia and preeclampsia-related complications. — Kluivers ACM, Neuman RI, Kalra B, Kumar A, Visser W, Danser AHJ et al. Pregnancy hypertension (2025)
[47]
Left Ventricular Hypertrophy in Women With a History of Preeclampsia. — Hauge MG, Damm P, Kofoed KF, Møller ELR, Lopez AG, Ersbøll AS et al. Hypertension (Dallas, Tex. : 1979) (2025)
[48]
Vitamin E supplementation and increased risk of gestational hypertension and preeclampsia in women undergoing assisted reproductive technologies. — Yang X, Dou Y, Hu L, Zhang X, Pang L, Jiang Y et al. Chinese medical journal (2025)
[49]
Preterm preeclampsia as an independent risk factor for thromboembolism in a large national cohort. — Slesnick L, Nienow-Birch M, Holmgren C, Harrison R American journal of obstetrics and gynecology (2025)
[50]
Real-world evidence for the utility of serum soluble fms-like tyrosine kinase 1/placental growth factor test for routine clinical evaluation of hospitalized women with hypertensive disorders of pregnancy. — Burns LP, Potchileev S, Mueller A, Azzi M, Premkumar A, Peterson J et al. American journal of obstetrics and gynecology (2025)
[51]
Preeclampsia's Cardiovascular Aftermath: A Comprehensive Review of Consequences for Mother and Offspring. — Kilkenny K, Frishman W Cardiology in review (2025)
[52]
The implication of pericardial effusion in the third trimester for preeclampsia and heart failure in high-risk pregnant women. — Kim H, Bae JG, Lee HJ, Lee S, Kim IC Journal of echocardiography (2025)
[53]
AT1-AA induced hypertension during pregnancy contributes to developmental programming of hypertension in female offspring. — Campbell N, Lemon JP, Helmich M, Solise D, Demesa A, Goolsby E et al. Journal of reproductive immunology (2025)
[54]
Differences between office, home, and 24-hour ambulatory blood pressure monitoring in pregnant women with preeclampsia and uncomplicated hypertension. — Szczepaniak-Chicheł L, Lipski D, Uruski P, Tykarski A Polish archives of internal medicine (2025)
[55]
Plasma from hypertensive pregnancy patients induce endothelial dysfunction even under atheroprotective shear stress. — Viana-Mattioli S, Fonseca-Alaniz MH, Pinheiro-de-Sousa I, Junior RR, Mastella MH, de Carvalho Cavalli R et al. Scientific reports (2025)
[56]
Effectiveness of low-dose aspirin in reducing the risk of preeclampsia in women with chronic hypertension: an integrative literature review. — Asiimwe P, Nambozi G, Brennaman L, Ngonzi J, Ruzaaza G BMC cardiovascular disorders (2025)
[57]
Impact of Blood Pressure Self-Management on Vascular Remodeling After Hypertensive Pregnancy. — Kitt J, Biasiolli L, Krasner S, Bateman PA, Cutler HR, Barr LC et al. Hypertension (Dallas, Tex. : 1979) (2025)
[58]
The different impacts of ambient air pollution exposure on the risks of gestational hypertension and preeclampsia in twin pregnancies. — Tang WZ, Xu HY, Cai QY, Pan YR, Chen HW, Jia YT et al. Toxicology and applied pharmacology (2025)
[59]
Comparison of two aspirin doses for the prophylaxis of pre-eclampsia in twin pregnancy: a multicenter retrospective study with propensity score matching. — Zorzato P, Torcia E, Carlin A, Familiari A, Cosmi E, Visentin S et al. American journal of obstetrics and gynecology (2025)
[60]
Placental ischemia during pregnancy induces hypertension, cerebral inflammation, and oxidative stress in dams postpartum. — Smith S, Smith J, Jones K, Castillo A, Wiemann N, Howard A et al. Hypertension in pregnancy (2025)
[61]
Subclinical Postpartum Renal Structure After Hypertensive Pregnancy Disorders. — Cutler HR, Kitt J, Sattwika PD, Finnigan LEM, Estevez-Fernandez A, Kenworthy Y et al. Hypertension (Dallas, Tex. : 1979) (2025)
[62]
First-trimester urinary protein levels and adverse pregnancy outcomes in low-risk women: implications for reassessing clinical thresholds. — Cai L, Zhu L, Liu Y, Yang C The journal of maternal-fetal & neonatal medicine : the official journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians (2025)
[63]
Factors associated with preeclampsia and the hypertensive disorders of pregnancy amongst Indigenous women of Canada, Australia, New Zealand, and the United States: A systematic review and meta-analysis. — Stephens J, Grande ED, Roberts T, Kerr M, Northcott C, Johnson T et al. Current hypertension reports (2025)
[64]
Is preeclampsia ever "mild?" Lessons on long-term consequences for offspring from a Danish registry-based study. — Jesudason S, Piccoli GB Kidney international (2025)
[65]
Unmasking hidden cardiovascular risk: masked hypertension, aortic stiffness and cardiac remodeling in women with prior preeclampsia. — Ülgen Kunak A, Yıldız G Scientific reports (2025)
[66]
Long-term cardiovascular repercussions in women with previous pregnancies complicated by severe hypertensive disease. — Verardino RGS, Andrade de Macedo T, Rodrigues S, Hong VC, Baptista FS, Bortolotto MRFL et al. Journal of hypertension (2025)
[67]
Hypertension and cardiometabolic disorders appear 5-10 years earlier in women with pre-eclampsia. — Janssen EBNJ, Ghossein-Doha C, Hooijschuur MCE, Mulder EG, Schiffer VMMM, Alers RJ et al. European journal of preventive cardiology (2025)
[68]
Role of biomarkers in identifying women at risk of hypertension and renal dysfunction on follow-up after severe preeclampsia. — Keepanasseril A, Ravi S, Dorairajan G, Zachariah B, Kundra P, Parameswaran S et al. Journal of human hypertension (2025)
[69]
Gastrin-releasing peptide in the paraventricular nucleus exerts hypertensive effects in preeclampsia. — Wang X, Ali MA, Liu X, Zeng M, Zeng Z, Yuan M et al. Neurochemistry international (2025)
[70]
[Preeclampsia: Guidelines for clinical practice from the French College of Obstetricians and Gynecologists]. — Sentilhes L, Schmitz T, Arthuis C, Barjat T, Berveiller P, Camilleri C et al. Gynecologie, obstetrique, fertilite & senologie (2024)
[71]
Maternal Hemodynamics from Preconception to Delivery: Research and Potential Diagnostic and Therapeutic Implications: Position Statement by Italian Association of Preeclampsia and Italian Society of Perinatal Medicine. — Vasapollo B, Zullino S, Novelli GP, Farsetti D, Ottanelli S, Clemenza S et al. American journal of perinatology (2024)
[72]
First and Second Stage Labor Management: ACOG Clinical Practice Guideline No. 8. Obstetrics and gynecology (2024)
[73]
Society for Maternal-Fetal Medicine Consult Series #71: Management of previable and periviable preterm prelabor rupture of membranes. — Battarbee AN, Osmundson SS, McCarthy AM, Louis JM American journal of obstetrics and gynecology (2024)
[74]
SMFM Consult Series #70: Management of short cervix in individuals without a history of spontaneous preterm birth. — Biggio J American journal of obstetrics and gynecology (2024)
[75]
Machine learning models for predicting preeclampsia: a systematic review. — Ranjbar A, Montazeri F, Ghamsari SR, Mehrnoush V, Roozbeh N, Darsareh F BMC pregnancy and childbirth (2024)
[76]
Advances in pathogenesis of preeclampsia. — Yang M, Wang M, Li N Archives of gynecology and obstetrics (2024)
[77]
Anti-hypertensive therapy for preeclampsia: a network meta-analysis and systematic review. — Wang T, Jiang R, Yao Y, Xu T, Li N Hypertension in pregnancy (2024)
[78]
The Pathophysiological, Genetic, and Hormonal Changes in Preeclampsia: A Systematic Review of the Molecular Mechanisms. — Chiang YT, Seow KM, Chen KH International journal of molecular sciences (2024)
[79]
Efficacy of vitamin D supplementation on the incidence of preeclampsia: a systematic review and meta-analysis. — Moghib K, Ghanm TI, Abunamoos A, Rajabi M, Moawad SM, Mohsen A et al. BMC pregnancy and childbirth (2024)
[80]
Utility of uterine artery Doppler ultrasound imaging in predicting preeclampsia during pregnancy: a meta-analysis. — Cao L, He B, Zhou Y, Chen T, Gao Y, Yao B Medical ultrasonography (2024)
[81]
Metformin use and preeclampsia risk in women with diabetes: a two-country cohort analysis. — Gordon H, Salim N, Tong S, Walker S, De Silva M, Cluver C et al. BMC medicine (2024)
[82]
Raised levels of chemerin in women with preeclampsia: A meta-analysis. — Xie Y, Quan X, Yang X Biomolecules & biomedicine (2024)
[83]
Investigating genetic links between blood metabolites and preeclampsia. — Lin Q, Li S, Wang H, Zhou W BMC women's health (2024)
[84]
Investigation of the linkage between TNF-alfa rs1800629 polymorphism and preeclampsia risk: A meta-analysis. — Shafiul Hossen M, Abdul Aziz M, Abdul Barek M, Safiqul Islam M Cytokine (2024)
[85]
Does probiotic ingestion reduce the risk of preeclampsia? A systematic review. — Valiati N, Puel EM, Stefani CM, Lataro RM Applied physiology, nutrition, and metabolism = Physiologie appliquee, nutrition et metabolisme (2024)
[86]
The Beneficial Effects of Antenatal Magnesium (BEAM) Sulfate Trial. — Rouse DJ Clinical obstetrics and gynecology (2024)
[87]
Preeclampsia - A patient's perspective. — Mark D, James JL Placenta (2024)
[88]
Advancements in microRNA-based electrochemical biosensors for preeclampsia detection. — K P A, Sekar D Hypertension research : official journal of the Japanese Society of Hypertension (2024)
[89]
Angiogenic factors for early prediction of preeclampsia. — Akasaki Y Hypertension research : official journal of the Japanese Society of Hypertension (2024)
[90]
Association of Race and Ethnicity and Social Factors With Postpartum Primary Care or Cardiology Follow-Up Visits Among Individuals With Preeclampsia. — Countouris ME, Shapero KS, Swabe G, Hauspurg A, Davis EM, Magnani JW Journal of the American Heart Association (2024)
[91]
The ABCs of post-preeclampsia outpatient nephrology care: the Le Mans strategy. — Piccoli GB, De Marco O, Njandjo L, Chevé MT, Torreggiani M Journal of nephrology (2024)
[92]
Emergency cerclage: Neonatal outcomes and evaluation of prognostic scores - A decade of experience at a tertiary center. — Nkobetchou M, Girault A, Goffinet F, Le Ray C European journal of obstetrics, gynecology, and reproductive biology (2024)
[93]
Cervical Length Ultrasound for the Evaluation of Preterm Labor: A Survey of National Use and Review of Evidence. — Boelig RC, Mcintosh J, Feltovich H, House M American journal of perinatology (2024)
[94]
A national survey on current practice of ultrasound in labor ward. — Mappa I, Masturzo B, Carbone IF, Kiener A, Maruotti GM, Pintucci A et al. Journal of perinatal medicine (2024)
[95]
Physician's Knowledge and Practices Surrounding Low-Dose Aspirin for Preeclampsia Risk Reduction. — Martinez-King LC, Machiorlatti M, Ogburn T, Salcedo J American journal of perinatology (2024)
[96]
Obstetric care provider's knowledge about the use of low dose aspirin for preeclampsia prevention in low and middle income countries: a systematic review and meta-analysis. — Lake ES, Ayele M, Tilahun BD, Erega BB, Belay AS, Yilak G BMC pregnancy and childbirth (2024)
[97]
Optimizing the length of the second stage and management of pushing. — Cahill AG, Macones GA American journal of obstetrics and gynecology (2024)
[98]
Quality of analgesic care in labor: A cross-sectional study of the first national register-based benchmarking system. — Tascón Padrón L, Emrich NLA, Strizek B, Schleußner E, Dreiling J, Komann M et al. International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics (2024)
[99]
Effect of early vitamin D supplementation on the incidence of preeclampsia in primigravid women: a randomised clinical trial in Eastern Democratic Republic of the Congo. — Kabuyanga RK, Tugirimana PL, Sifa B, Balezi M, Dikete ME, Mitangala PN et al. BMC pregnancy and childbirth (2024)
[100]
Preeclampsia and the Retina. — Soullane S, Rhéaume MA, Auger N Current hypertension reports (2024)

Share:Twitter Reddit LinkedIn